Protein adducts as biomarkers of exposure to organophosphorus compounds

Toxicology

Volumn 307, Issue , 2013, Pages 46-54

  Marsillach, Judit ^a   Costa, Lucio G ^b,c   Furlong, Clement E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Biomarkers; Mass spectrometry; Organophosphates; Protein adducts

Indexed keywords

ACETYLCHOLINESTERASE; ACYLAMINO ACID RELEASING ENZYME; ALBUMIN; BIOLOGICAL MARKER; CARBOXYLESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CYTOCHROME P450; ESTERASE; HYDROLASE; NEUROTOXIC ESTERASE; ORGANOPHOSPHORUS COMPOUND; PROTEIN; PROTEINASE; PYROPHOSPHATE; SERINE; TETRAETHYL PYROPHOSPHATE; TRANSFERRIN; TRIACYLGLYCEROL LIPASE; TUBULIN; UNCLASSIFIED DRUG; ACYLAMINOACYL PEPTIDASE; ACYLAMINOACYL-PEPTIDASE; PEPTIDE HYDROLASE; SERUM ALBUMIN;

ANALYTIC METHOD; ARTICLE; BIOLOGICAL ACTIVITY; BIOLOGICAL MONITORING; BRADYCARDIA; CHOLINESTERASE BLOOD LEVEL; COMA; CONVULSION; COVALENT BOND; DEATH; DIARRHEA; DIZZINESS; ENVIRONMENTAL EXPOSURE; ENZYMATIC ASSAY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HEADACHE; HEALTH HAZARD; HUMAN; LACRIMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; RISK ASSESSMENT; SALIVATION; TANDEM MASS SPECTROMETRY; TREMOR; DRUG EFFECT; METABOLISM; REVIEW;

ACETYLCHOLINESTERASE; BIOLOGICAL MARKERS; BUTYRYLCHOLINESTERASE; CARBOXYLESTERASE; ENVIRONMENTAL EXPOSURE; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; PEPTIDE HYDROLASES; PROTEINS; SERUM ALBUMIN;

MLCS; MLOWN;

EID: 84880054560     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.12.007     Document Type: Article

References (117)

1. Akassoglou K., Malester B., Xu J., Tessarollo L., Rosenbluth J., Chao M.V. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5075-5080.
2. Aldridge W.N. The differentiation of true and pseudo cholinesterase by organophosphorus compounds. Biochem. J. 1953, 53:62-67.
3. Angerer J., Ewers U., Wilhelm M. Human biomonitoring: state of the art. Int. J. Hyg. Environ. Health 2007, 210:201-228.
4. Aryal U.K., Lin C.T., Kim J.S., Heibeck T.H., Wang J., Qian W.J., Lin Y. Identification of phosphorylated butyrylcholinesterase in human plasma using immunoaffinity purification and mass spectrometry. Anal. Chim. Acta 2012, 723:68-75.
5. Augustinsson K.B., Nachmansohn D. Studies on cholinesterase: VI. Kinetics of the inhibition of acetylcholine esterase. J. Biol. Chem. 1949, 179:543-559.
6. Barelli A., Soave P.M., Del Vicario M., Barelli R. New experimental oximes in the management of organophosphorus pesticides poisoning. Minerva Anestesiol. 2011, 77:1197-1203.
7. Barr D.B., Angerer J. Potential uses of biomonitoring data: a case study using the organophosphorus pesticides chlorpyrifos and malathion. Environ. Health Perspect. 2006, 114:1763-1769.
8. Barr D.B., Bravo R., Weerasekera G., Caltabiano L.M., Whitehead R.D., Olsson A.O., Caudill S.P., Schober S.E., Pirkle J.L., Sampson E.J., Jackson R.J., Needham L.L. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ. Health Perspect. 2004, 112:186-200.
9. Black R.M., Harrison J.M., Read R.W. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch. Toxicol. 1999, 73:123-126.
10. Bolognesi C. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat. Res. 2003, 543:251-272.
11. Bravo R., Caltabiano L.M., Weerasekera G., Whitehead R.D., Fernandez C., Needham L.L., Bradman A., Barr D.B. Measurement of dialkyl phosphate metabolites of organophosphorus pesticides in human urine using lyophilization with gas chromatography-tandem mass spectrometry and isotope dilution quantification. J. Expo. Anal. Environ. Epidemiol. 2004, 14:249-259.
12. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 2004, 17:983-998.
13. Casida J.E., Nomura D.K., Vose S.C., Fujioka K. Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. Chem. Biol. Interact. 2008, 175:355-364.
14. Chaiken I.M., Smith E.L. Reaction of a specific tyrosine residue of papain with diisopropylfluorophosphate. J. Biol. Chem. 1969, 244:4247-4250.
15. Chanda S.M., Mortensen S.R., Moser V.C., Padilla S. Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison. Fundam. Appl. Toxicol. 1997, 38:148-157.
16. Chatonnet A., Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 1989, 260:625-634.
17. Clarke N.J., Hoofnagle A.N. Mass spectrometry continues its march into the clinical laboratory. Clin. Lab. Med. 2011, 31:ix-xi.
18. Cocker J., Mason H.J., Garfitt S.J., Jones K. Biological monitoring of exposure to organophosphate pesticides. Toxicol. Lett. 2002, 134:97-103.
19. Costa L.G. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ. Health Perspect. 1996, 104(Suppl. 1):55-67.
20. Costa L.G. Current issues in organophosphate toxicology. Clin. Chim. Acta 2006, 366:1-13.
21. Ding S.J., Carr J., Carlson J.E., Tong L., Xue W., Li Y., Schopfer L.M., Li B., Nachon F., Asojo O., Thompson C.M., Hinrichs S.H., Masson P., Lockridge O. Five tyrosines and two serines in human albumin are labeled by the organophosphorus agent FP-biotin. Chem. Res. Toxicol. 2008, 21:1787-1794.
22. Doorn J.A., Schall M., Gage D.A., Talley T.T., Thompson C.M., Richardson R.J. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers. Toxicol. Appl. Pharmacol. 2001, 176:73-80.
23. Dudek B.R., Richardson R.J. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. Biochem. Pharmacol. 1982, 31:1117-1121.
24. Duysen E.G., Li B., Xie W., Schopfer L.M., Anderson R.S., Broomfield C.A., Lockridge O. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 2001, 299:528-535.
25. Eaton D.L., Daroff R.B., Autrup H., Bridges J., Buffler P., Costa L.G., Coyle J., McKhann G., Mobley W.C., Nadel L., Neubert D., Schulte-Hermann R., Spencer P.S. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit. Rev. Toxicol. 2008, 38(Suppl. 2):1-125.
26. Eddleston M., Eyer P., Worek F., Juszczak E., Alder N., Mohamed F., Senarathna L., Hittarage A., Azher S., Jeganathan K., Jayamanne S., von Meyer L., Dawson A.H., Sheriff M.H., Buckley N.A. Pralidoxime in acute organophosphorus insecticide poisoning - a randomised controlled trial. PLoS Med. 2009, 6:e1000104.
27. Egeghy P.P., Cohen, Hubal E.A., Tulve N.S., Melnyk L.J., Morgan M.K., Fortmann R.C., Sheldon L.S. Review of pesticide urinary biomarker measurements from selected US EPA children's observational exposure studies. Int. J. Environ. Res. Public Health 2011, 8:1727-1754.
28. Elhanany E., Ordentlich A., Dgany O., Kaplan D., Segall Y., Barak R., Velan B., Shafferman A. Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem. Res. Toxicol. 2001, 14:912-918.
29. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
30. Emmett E.A., Lewis P.G., Tanaka F., Bleecker M., Fox R., Darlington A.C., Synkowski D.R., Dannenberg A.M., Taylor W.J., Levine M.S. Industrial exposure to organophosphorus compounds. Studies of a group of workers with a decrease in esterase-staining monocytes. J. Occup. Med. 1985, 27:905-914.
31. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 2003, 22:165-190.
32. Fidder A., Hulst A.G., Noort D., de Ruiter R., van der Schans M.J., Benschop H.P., Langenberg J.P. Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 2002, 15:582-590.
33. Fujino T., Tada T., Beppu M., Kikugawa K. Purification and characterization of a serine protease in erythrocyte cytosol that is adherent to oxidized membranes and preferentially degrades proteins modified by oxidation and glycation. J. Biochem. 1998, 124:1077-1085.
34. Fujino T., Watanabe K., Beppu M., Kikugawa K., Yasuda H. Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim. Biophys. Acta 2000, 1478:102-112.
35. Garabrant D.H., Aylward L.L., Berent S., Chen Q., Timchalk C., Burns C.J., Hays S.M., Albers J.W. Cholinesterase inhibition in chlorpyrifos workers: characterization of biomarkers of exposure and response in relation to urinary TCPy. J. Expo. Sci. Environ. Epidemiol. 2009, 19:634-642.
36. Glynn P. Neuropathy target esterase. Biochem. J. 1999, 344(Pt. 3):625-631.
37. Glynn P., Holton J.L., Nolan C.C., Read D.J., Brown L., Hubbard A., Cavanagh J.B. Neuropathy target esterase: immunolocalization to neuronal cell bodies and axons. Neuroscience 1998, 83:295-302.
38. Griffiths J.T., Sterns C.R., Thompson W.L. Parathion hazards encountered spraying citrus in Florida. J. Econ. Entomol. 1951, 44:160-163.
39. Grigoryan H., Schopfer L.M., Thompson C.M., Terry A.V., Masson P., Lockridge O. Mass spectrometry identifies covalent binding of soman, sarin, chlorpyrifos oxon, diisopropyl fluorophosphate, and FP-biotin to tyrosines on tubulin: a potential mechanism of long term toxicity by organophosphorus agents. Chem. Biol. Interact. 2008, 175:180-186.
40. Gutmann L., Besser R. Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations. Semin. Neurol. 1990, 10:46-51.
41. Henderson R.F., Bechtold W.E., Bond J.A., Sun J.D. The use of biological markers in toxicology. Crit. Rev. Toxicol. 1989, 20:65-82.
42. Imai T. Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab. Pharmacokinet. 2006, 21:173-185.
43. Jiang W., Duysen E.G., Hansen H., Shlyakhtenko L., Schopfer L.M., Lockridge O. Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in the brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphorus agents. Toxicol. Sci. 2010, 115:183-193.
44. John H., Worek F., Thiermann H. LC-MS-based procedures for monitoring of toxic organophosphorus compounds and verification of pesticide and nerve agent poisoning. Anal. Bioanal. Chem. 2008, 391:97-116.
45. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem. J. 1969, 114:711-717.
46. Johnson M.K. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J. Neurochem. 1974, 23:785-789.
47. Jokanovic M., Kosanovic M., Brkic D., Vukomanovic P. Organophosphate induced delayed polyneuropathy in man: an overview. Clin. Neurol. Neurosurg. 2011, 113:7-10.
48. Kapka-Skrzypczak L., Cyranka M., Skrzypczak M., Kruszewski M. Biomonitoring and biomarkers of organophosphate pesticides exposure - state of the art. Ann. Agric. Environ. Med. 2011, 18:294-303.
49. Kim J.H., Stevens R.C., MacCoss M.J., Goodlett D.R., Scherl A., Richter R.J., Suzuki S.M., Furlong C.E. Identification and characterization of biomarkers of organophosphorus exposures in humans. Adv. Exp. Med. Biol. 2010, 660:61-71.
50. Kobayashi K., Smith J.A. Acyl-peptide hydrolase from rat liver. Characterization of enzyme reaction. J. Biol. Chem. 1987, 262:11435-11445.
51. Koelle G.B., Gilman A. The relationship between cholinesterase inhibition and the pharmacological action of di-isopropyl fluorophosphate (DFP). J. Pharmacol. Exp. Ther. 1946, 87:421-434.
52. Lee M.J., Waters H.C. Inhibition of monocyte esterase activity by organophosphate insecticides. Blood 1977, 50:947-951.
53. Lepage L., Schiele F., Gueguen R., Slest G. Total cholinesterase in plasma: biological variations and reference limits. Clin. Chem. 1985, 31:546-550.
54. Li Y., Dinsdale D., Glynn P. Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in mammalian cells. J. Biol. Chem. 2003, 278:8820-8825.
55. Li B., Schopfer L.M., Hinrichs S.H., Masson P., Lockridge O. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411. Anal. Biochem. 2007, 361:263-272.
56. Li H., Tong L., Schopfer L.M., Masson P., Lockridge O. Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase. Chem. Biol. Interact. 2008, 175:68-72.
57. Li B., Nachon F., Froment M.T., Verdier L., Debouzy J.C., Brasme B., Gillon E., Schopfer L.M., Lockridge O., Masson P. Binding and hydrolysis of soman by human serum albumin. Chem. Res. Toxicol. 2008, 21:421-431.
58. Li B., Schopfer L.M., Grigoryan H., Thompson C.M., Hinrichs S.H., Masson P., Lockridge O. Tyrosines of human and mouse transferrin covalently labeled by organophosphorus agents: a new motif for binding to proteins that have no active site serine. Toxicol. Sci. 2009, 107:144-155.
59. Li B., Ricordel I., Schopfer L.M., Baud F., Megarbane B., Masson P., Lockridge O. Dichlorvos, chlorpyrifos oxon and aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose. J. Appl. Toxicol. 2010, 30:559-565.
60. Li B., Ricordel I., Schopfer L.M., Baud F., Megarbane B., Nachon F., Masson P., Lockridge O. Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos. Toxicol. Sci. 2010, 116:23-31.
61. Liu Y., Patricelli M.P., Cravatt B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14694-14699.
62. Liyasova M., Li B., Schopfer L.M., Nachon F., Masson P., Furlong C.E., Lockridge O. Exposure to tri-o-cresyl phosphate detected in jet airplane passengers. Toxicol. Appl. Pharmacol. 2011, 256:337-347.
63. Lockridge O., Schopfer L.M. Review of tyrosine and lysine as new motifs for organophosphate binding to proteins that have no active site serine. Chem. Biol. Interact. 2010, 187:344-348.
64. Lotti M., Moretto A. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem. Biol. Interact. 1999, 119-120:519-524.
65. Lush M.J., Li Y., Read D.J., Willis A.C., Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem. J. 1998, 332(Pt. 1):1-4.
66. Mackworth J.F., Webb E.C. The inhibition of serum cholinesterase by alkyl fluorophosphonates. Biochem. J. 1948, 42:91-95.
67. Makhaeva G.F., Malygin V.V., Strakhova N.N., Sigolaeva L.V., Sokolovskaya L.G., Eremenko A.V., Kurochkin I.N., Richardson R.J. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Hum. Exp. Toxicol. 2007, 26:273-282.
68. Manoharan I., Boopathy R., Darvesh S., Lockridge O. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin. Chim. Acta 2007, 378:128-135.
69. Maroni M., Colosio C., Ferioli A., Fait A. Biological monitoring of pesticide exposure: a review introduction. Toxicology 2000, 143:1-118.
70. Marsillach J., Richter R.J., Kim J.H., Stevens R.C., MacCoss M.J., Tomazela D., Suzuki S.M., Schopfer L.M., Lockridge O., Furlong C.E. Biomarkers of organophosphorus (OP) exposures in humans. Neurotoxicology 2011, 32:656-660.
71. Marsillach, J., Hsieh, E.J., Richter, R.J., MacCoss, M.J., Furlong, C.E., 2012. Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures. Chem. Biol. Interact, in press.
72. Mason H.J. The recovery of plasma cholinesterase and erythrocyte acetylcholinesterase activity in workers after over-exposure to dichlorvos. Occup. Med. (Lond) 2000, 50:343-347.
73. Masson P., Nachon F., Lockridge O. Structural approach to the aging of phosphylated cholinesterases. Chem. Biol. Interact. 2010, 187:157-162.
74. Maxwell D.M. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 1992, 114:306-312.
75. Mazur A., Bodansky O. The mechanism of in vitro and in vivo inhibition of cholinesterase activity by diisopropyl fluorophosphate. J. Biol. Chem. 1946, 163:261-276.
76. Means G.E., Wu H.L. The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate. Arch. Biochem. Biophys. 1979, 194:526-530.
77. Mock D.M., Lankford G.L., Widness J.A., Burmeister L.F., Kahn D., Strauss R.G. Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (Paris) 1999, 39:156-162.
78. Morgan M.K., Sheldon L.S., Croghan C.W., Jones P.A., Robertson G.L., Chuang J.C., Wilson N.K., Lyu C.W. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments. J. Expo. Anal. Environ. Epidemiol. 2005, 15:297-309.
79. Morgan M.K., Sheldon L.S., Jones P.A., Croghan C.W., Chuang J.C., Wilson N.K. The reliability of using urinary biomarkers to estimate children's exposures to chlorpyrifos and diazinon. J. Expo. Sci. Environ. Epidemiol. 2011, 21:280-290.
80. Moser M., Stempfl T., Li Y., Glynn P., Buttner R., Kretzschmar D. Cloning and expression of the murine sws/NTE gene. Mech. Dev. 2000, 90:279-282.
81. Mourik J., de Jong L.P. Binding of the organophosphates parathion and paraoxon to bovine and human serum albumin. Arch. Toxicol. 1978, 41:43-48.
82. Murachi T., Inagami T., Yasui M. Evidence for alkylphosphorylation of tyrosyl residues of stem bromelain by diisopropylphosphorofluoridate. Biochemistry 1965, 4:2815-2825.
83. Myers D.K. Competition of the aliesterase in rat serum with the pseudo cholinesterase for diisopropyl fluorophosphonate. Science 1952, 115:568-570.
84. Myers D.K., Mendel B. Investigations on the use of eserine for the differentiation of mammalian esterases. Proc. Soc. Exp. Biol. Med. 1949, 71:357-360.
85. Nigg H.N., Knaak J.B. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev. Environ. Contam. Toxicol. 2000, 163:29-111.
86. Noort D., Fidder A., van der Schans M.J., Hulst A.G. Verification of exposure to organophosphates: generic mass spectrometric method for detection of human butyrylcholinesterase adducts. Anal. Chem. 2006, 78:6640-6644.
87. Ostergaard D., Viby-Mogensen J., Hanel H.K., Skovgaard L.T. Half-life of plasma cholinesterase. Acta Anaesthesiol. Scand. 1988, 32:266-269.
88. Pancetti F., Olmos C., Dagnino-Subiabre A., Rozas C., Morales B. Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: implication for the action of acylpeptide hydrolase. J. Toxicol. Environ. Health B Crit. Rev. 2007, 10:623-630.
89. Peeples E.S., Schopfer L.M., Duysen E.G., Spaulding R., Voelker T., Thompson C.M., Lockridge O. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol. Sci. 2005, 83:303-312.
90. Petroianu G.A. History of organophosphate synthesis: the very early days. Pharmazie 2010, 65:306-311.
91. Polhuijs M., Langenberg J.P., Benschop H.P. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol. Appl. Pharmacol. 1997, 146:156-161.
92. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2:161-181.
93. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7983-7987.
94. Quistad G.B., Klintenberg R., Casida J.E. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Toxicol. Sci. 2005, 86:291-299.
95. Racke K.D. Degradation of organophosphorus insecticides in environmental matrices. Organophosphates Chemistry, Fate and Effects 1992, Academic Press Inc., San Diego, pp. 47-72. J.E. Chambers, P.E. Levi (Eds.).
96. Raphel V., Giardina T., Guevel L., Perrier J., Dupuis L., Guo X.J., Puigserver A. Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa. Biochim. Biophys. Acta 1999, 1432:371-381.
97. Ray D.E., Richards P.G. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol. Lett. 2001, 120:343-351.
98. Read R.W., Riches J.R., Stevens J.A., Stubbs S.J., Black R.M. Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy. Arch. Toxicol. 2010, 84:25-36.
99. Redinbo M.R., Bencharit S., Potter P.M. Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem. Soc. Trans. 2003, 31:620-624.
100. Richards P., Johnson M., Ray D., Walker C. Novel protein targets for organophosphorus compounds. Chem. Biol. Interact. 1999, 119-120:503-511.
101. Richards P.G., Johnson M.K., Ray D.E. Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 2000, 58:577-583.
102. Saboori A.M., Newcombe D.S. Human monocyte carboxylesterase. Purification and kinetics. J. Biol. Chem. 1990, 265:19792-19799.
103. Sanger F. Amino-acid sequences in the active centres of certain enzymes (Pedler lecture). Proc. Chem. Soc. 1963, 76-83.
104. Satoh T., Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 1998, 38:257-288.
105. Schopfer L.M., Champion M.M., Tamblyn N., Thompson C.M., Lockridge O. Characteristic mass spectral fragments of the organophosphorus agent FP-biotin and FP-biotinylated peptides from trypsin and bovine albumin (Tyr410). Anal. Biochem. 2005, 345:122-132.
106. Schopfer L.M., Furlong C.E., Lockridge O. Development of diagnostics in the search for an explanation of aerotoxic syndrome. Anal. Biochem. 2010, 404:64-74.
107. Shafik M.T., Enos H.F. Determination of metabolic and hydrolytic products of organophosphorus pesticide chemicals in human blood and urine. J. Agric. Food Chem. 1969, 17:1187-1189.
108. Sporty J.L., Lemire S.W., Jakubowski E.M., Renner J.A., Evans R.A., Williams R.F., Schmidt J.G., van der Schans M.J., Noort D., Johnson R.C. Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum. Anal. Chem. 2010, 82:6593-6600.
109. Stevens R.C., Suzuki S.M., Cole T.B., Park S.S., Richter R.J., Furlong C.E. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12780-12784.
110. Su M.Q., Kinoshita F.K., Frawley J.P., DuBois K.P. Comparative inhibition of aliesterases and cholinesterase in rats fed eighteen organophosphorus insecticides. Toxicol. Appl. Pharmacol. 1971, 20:241-249.
111. Sudakin D.L., Stone D.L. Dialkyl phosphates as biomarkers of organophosphates: the current divide between epidemiology and clinical toxicology. Clin. Toxicol. (Phila.) 2011, 49:771-781.
112. Sun J., Lynn B.C. Development of a MALDI-TOF-MS method to identify and quantify butyrylcholinesterase inhibition resulting from exposure to organophosphate and carbamate pesticides. J. Am. Soc. Mass Spectrom. 2007, 18:698-706.
113. Thompson C.M., Prins J.M., George K.M. Mass spectrometric analyses of organophosphate insecticide oxon protein adducts. Environ. Health Perspect. 2010, 118:11-19.
114. van Tienhoven M., Atkins J., Li Y., Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J. Biol. Chem. 2002, 277:20942-20948.
115. Whiteaker J.R., Zhao L., Zhang H.Y., Feng L.C., Piening B.D., Anderson L., Paulovich A. Antibody-based enrichment of peptides on magnetic beads for mass spectrometry-based quantification of serum biomarkers. Anal. Biochem. 2007, 362:44-54.
116. Wilson B.W., Arrieta D.E., Henderson J.D. Monitoring cholinesterases to detect pesticide exposure. Chem. Biol. Interact. 2005, 157-158:253-256.
117. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 2003, 33:477-485.